Arialys Therapeutics is a pre-clinical stage company dedicated to exploring the role of auto-antibodies in neuroscience. By investigating how the immune system influences central nervous system health, disease progression, and treatment strategies, Arialys aims to pave the way for innovative therapeutic solutions in neuroimmunology.
National Ranking33912th
in United States Regional Ranking37212th
in North America Global Ranking89637th
worldwide Rankings by